WebAbstract. Since its isolation in the 1930s, digoxin has played a pivotal role in the treatment of cardiac conditions including heart failure and supraventricular tachyarrhythmias. The parasympathomimetic activity makes digoxin a reasonable option for controlling ventricular rate in atrial fibrillation (AF). However, the unique pharmacokinetic ... WebMay 9, 2024 · The risk of death in patients with atrial fibrillation in the trial was directly proportional to serum digoxin level with every 0.5 ng/mL increase in digoxin level, increasing the risk of death by 19%. A digoxin level of >1.2 ng/mL was associated with an increase in mortality of 56%. Additional “prevalence” analysis was conducted to compare ...
Digoxin and Mortality in Patients With Atrial Fibrillation
WebDec 9, 2024 · Digoxin is a cardiac medication that is used in the treatment of various heart conditions, including atrial fibrillation, atrial flutters, and congestive heart failure. As a medication that interacts with the electrical … WebBackground: Digoxin is a cardiac glycoside, derived from the plant Digitalis purpurea. For many years digitalis has been widely used in the treatment of heart failure (HF), owing to its cardiotonic and neurohormonal effects and atrial fibrillation (AF), due to its parasympathomimetic effect on the AV node. Objective: The aim of this paper is to ... michigan famous people
Clinical Pharmacology & Toxicology Pearl of the Week
WebDigoxin calculator to determine the optimal maintenance dose of digoxin for both heart failure and atrial fibrillation patients, based on the Bauman-DiDomenico and Koup-Jusko methods. Web- When monitoring digoxin, blood levels should be drawn no sooner than 6 hours after the most recent dose. - Digoxin levels should be interpreted and acted on based on clinical signs and symptoms. - Therapeutic digoxin levels should fall between 0.6 – 1.2 nmol/L despite reference ranges of up to 2.6 nmol/L. WebOct 31, 2024 · Digoxin, Mortality Risk, and Serum Digoxin Concentration. Over the past decade, numerous studies have suggested that digoxin use in patients with atrial fibrillation increases mortality risk. 5, 6 A meta-analysis of 11 observational studies found that the use of digoxin in patients with atrial fibrillation was associated with a 17% … the north face 評価